Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.

Extremely high cancer incidence associated with patients with Fanconi anemia (FA) suggests the importance of the FA signaling pathway in the suppression of non-FA human tumor development. Indeed, we found that an impaired FA signaling pathway substantially contributes to the development of non-FA hu...

Full description

Bibliographic Details
Main Authors: Hwan Ki Park, Hong Wang, Jun Zhang, Suvamoy Datta, Peiwen Fei
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-10-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2954165?pdf=render
_version_ 1819211758757216256
author Hwan Ki Park
Hong Wang
Jun Zhang
Suvamoy Datta
Peiwen Fei
author_facet Hwan Ki Park
Hong Wang
Jun Zhang
Suvamoy Datta
Peiwen Fei
author_sort Hwan Ki Park
collection DOAJ
description Extremely high cancer incidence associated with patients with Fanconi anemia (FA) suggests the importance of the FA signaling pathway in the suppression of non-FA human tumor development. Indeed, we found that an impaired FA signaling pathway substantially contributes to the development of non-FA human tumors. However, the mechanisms underlying the function of the FA pathway remain less understood. Using RNA interfering approach in combining with cell proliferation and reporter assays, we showed that the function of FA signaling pathway is at least partly mediated through coupling with hRad6/hRad18 signaling (HHR6 pathway). We previously reported that FANCD2 monoubiquitination, a hallmark of the FA pathway activation, can be regulated by HHR6. Here we found that hRad18 can also regulate activation of the FA pathway. More importantly, we found that FANCD2 is capable of modulating activity of DNA translesion synthesis polymerase eta, an effector of HHR6 pathway. These results provide novel insights into how the FA pathway is intertwined with HHR6 pathway to maintain chromosomal stability and suppress the development of human cancer, representing an important conceptual advance in the field of FA cancer research.
first_indexed 2024-12-23T06:32:10Z
format Article
id doaj.art-7e29b88342ee4465bf758bd62d8f945d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T06:32:10Z
publishDate 2010-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7e29b88342ee4465bf758bd62d8f945d2022-12-21T17:56:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-10-01510e1331310.1371/journal.pone.0013313Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.Hwan Ki ParkHong WangJun ZhangSuvamoy DattaPeiwen FeiExtremely high cancer incidence associated with patients with Fanconi anemia (FA) suggests the importance of the FA signaling pathway in the suppression of non-FA human tumor development. Indeed, we found that an impaired FA signaling pathway substantially contributes to the development of non-FA human tumors. However, the mechanisms underlying the function of the FA pathway remain less understood. Using RNA interfering approach in combining with cell proliferation and reporter assays, we showed that the function of FA signaling pathway is at least partly mediated through coupling with hRad6/hRad18 signaling (HHR6 pathway). We previously reported that FANCD2 monoubiquitination, a hallmark of the FA pathway activation, can be regulated by HHR6. Here we found that hRad18 can also regulate activation of the FA pathway. More importantly, we found that FANCD2 is capable of modulating activity of DNA translesion synthesis polymerase eta, an effector of HHR6 pathway. These results provide novel insights into how the FA pathway is intertwined with HHR6 pathway to maintain chromosomal stability and suppress the development of human cancer, representing an important conceptual advance in the field of FA cancer research.http://europepmc.org/articles/PMC2954165?pdf=render
spellingShingle Hwan Ki Park
Hong Wang
Jun Zhang
Suvamoy Datta
Peiwen Fei
Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
PLoS ONE
title Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
title_full Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
title_fullStr Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
title_full_unstemmed Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
title_short Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
title_sort convergence of rad6 rad18 and fanconi anemia tumor suppressor pathways upon dna damage
url http://europepmc.org/articles/PMC2954165?pdf=render
work_keys_str_mv AT hwankipark convergenceofrad6rad18andfanconianemiatumorsuppressorpathwaysupondnadamage
AT hongwang convergenceofrad6rad18andfanconianemiatumorsuppressorpathwaysupondnadamage
AT junzhang convergenceofrad6rad18andfanconianemiatumorsuppressorpathwaysupondnadamage
AT suvamoydatta convergenceofrad6rad18andfanconianemiatumorsuppressorpathwaysupondnadamage
AT peiwenfei convergenceofrad6rad18andfanconianemiatumorsuppressorpathwaysupondnadamage